Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
Scientists developed a platform, GOOSE, allowing them to design disordered prote...
The team integrated high-resolution spatial transcriptomics, single-cell RNA seq...
In this episode of GEN's Touching Base, editors discuss business news from Axiom...
The metabolite 10-hydroxystearic acid (10-HSA), from Lactiplantibacillus plantar...
Kris DeVault is desperate. His son, Brody, was born in March 2023. It wasn’t lon...
As of this week in Montana, any biotech company with an experimental drug has a ...
LTG-001 achieved the primary endpoint of the Phase IIb LTG-001-010 trial (NCT071...
Elix and the University of Vienna will partner to bridge the gap between advance...
The collaboration brings together Celonic’s expertise in cell line development, ...
A Phase III trial found the donor-derived cell therapy deramiocel slowed arm mus...
By precisely altering the huntingtin gene rather than switching it off, an in vi...
A GWAS meta-analysis including 2.5 million individuals identified 26 genetic ris...
In a new publishing deal, Causaly and Sage have announced a partnership to bring...
The researchers identified Nys34 as a leading candidate after it demonstrated th...
Manufacturing costs for therapies based on adeno-associated viruses (AAV) could ...
NIBRT predicts that the market for GLP-1 receptor agonist-based diabetes and obe...